Showing 71-80 of 1820 results for "".
- Pain Managementhttps://practicalneurology.com/diseases-diagnoses/headache-pain/pn1008_10-pdf/30986/Choosing Between Short- and Long-Acting Opioids in Chronic Pain ManagementIn the realm of chronic pain management, selecting the appropriate opioid analgesic—whether short-acting or long-acting—remains a nuanced decision due to limited comparative data. Charles Argoff, MD, in his recent article for
Neurology Q&A: What Neurologists Should Know About Headache Patients and Complimentary Medicine
https://practicalneurology.com/diseases-diagnoses/headache-pain/neurology-qa-what-neurologists-should-know-about-headache-patients-and-complimentary-medicine/30804/Those who suffer from headaches may be more likely to use CAM than others are. Here's what research shows.A Q&A with Rebecca E. Wells, MD, MPHConcussion and Epilepsy: What is the Link?
https://practicalneurology.com/diseases-diagnoses/epilepsy-seizures/concussion-and-epilepsy-what-is-the-link/30769/Individuals who suffer a traumatic brain injury are at increased risk for developing seizures. Here's an update to the current evidence and implications for monitoring.Insights from G. Alexander Hishaw, MDEarly Recognition + Earlier Intervention = Slowing the Progression in Mild Cognitive Impairment / Early Alzheimer’s
https://practicalneurology.com/programs/cme/early-recognition-earlier-intervention-slowing-the-progression-in-mild-cognitive-impairment-early-alzheimers/24279/Tune in to learn about early recognition and the latest on diagnosing and treating patients with mild cognitive impairment and early Alzheimer’s.About the Cover Artist
https://practicalneurology.com/diseases-diagnoses/stroke/about-the-cover-artist-7/31869/During recovery from a stroke-like event, Rick Johnston found he had become a prolific, talented painter.Mood Disorders Following Traumatic Brain Injury
https://practicalneurology.com/diseases-diagnoses/tbi/mood-disorders-following-traumatic-brain-injury/31994/Update on mood disorders, including depressive disorder and anxiety disorders along with accompanying symptoms, following TBIAntisense Oligonucleotide Therapies
https://practicalneurology.com/diseases-diagnoses/movement-disorders/antisense-oligonucleotide-therapies/31573/Antisense oligonucleotides are a promising new therapeutic class being studied for the treatment of movement disorders.- Business Advisorhttps://practicalneurology.com/columns/practice-management/business-advisor/31385/Optimizing Neurology Practice Management: Insights from Parkinson’s LawNeurology practitioners possess extensive knowledge of neurological disorders such as Parkinson’s disease, yet many remain unaware of Parkinson’s Law, a concept introduced by sociologist C. Northcote Parkinson in the 1950s. Parki
- Building a better UPDRShttps://practicalneurology.com/columns/practice-management/building-a-better-updrs/31010/Since the late 1980s, the Unified Parkinson’s Disease Rating Scale (UPDRS) has been a cornerstone in assessing Parkinson’s Disease (PD), primarily focusing on motor symptoms such as finger tapping, fist opening, and rising from a chair. However, over the past two decades, advancements in PD research
- Pain Managementhttps://practicalneurology.com/diseases-diagnoses/headache-pain/pn0607-painmanagemnt-pdf/31166/Herbal Supplements Pose Significant Risks in Neurological CareHerbal supplements, often perceived as natural and safe, present considerable risks for patients undergoing neurological treatments. Dr. Charles Argoff, in Practical Neurology, highlights the critical need for healthcare professionals to